198 related articles for article (PubMed ID: 36346063)
21. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
Alamneh EA; Chalmers L; Bereznicki LR
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
[TBL] [Abstract][Full Text] [Related]
22. Association of Neighborhood Disadvantage and Anticoagulation for Patients with Atrial Fibrillation in the Veterans Health Administration: the REACH-AF Study.
McDermott A; Kim N; Hausmann LRM; Magnani JW; Good CB; Litam TMA; Mor MK; Omole TD; Gellad WF; Fine MJ; Essien UR
J Gen Intern Med; 2023 Mar; 38(4):848-856. PubMed ID: 36151447
[TBL] [Abstract][Full Text] [Related]
23. Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010-2016.
Ardeshirrouhanifard S; An H; Goyal RK; Raji MA; Segal JB; Alexander GC; Mehta HB
Pharmacotherapy; 2022 May; 42(5):375-386. PubMed ID: 35364622
[TBL] [Abstract][Full Text] [Related]
24. Atrial Fibrillation Patients on Warfarin and Their Transition to Direct Oral Anticoagulants.
Collins P; Lewin A; Vincze Irving N; Sylvester K; Fanikos J; Goldhaber SZ; Connors JM
Crit Pathw Cardiol; 2021 Jun; 20(2):103-107. PubMed ID: 33337730
[TBL] [Abstract][Full Text] [Related]
25. Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study.
Durand M; Schnitzer ME; Pang M; Carney G; Eltonsy S; Filion KB; Fisher A; Jun M; Kuo IF; Renoux C; Paterson JM; Quail J; Matteau A;
CMAJ Open; 2020; 8(4):E877-E886. PubMed ID: 33355273
[TBL] [Abstract][Full Text] [Related]
26. Comparison of real-world outcomes in patients with nonvalvular atrial fibrillation treated with direct oral anticoagulant agents or warfarin.
Datar M; Crivera C; Rozjabek H; Abbass IM; Xu Y; Pasquale MK; Schein JR; Andrews GA
Am J Health Syst Pharm; 2019 Feb; 76(5):275-285. PubMed ID: 30698654
[TBL] [Abstract][Full Text] [Related]
27. Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight.
Lee SR; Choi EK; Park CS; Han KD; Jung JH; Oh S; Lip GYH
J Am Coll Cardiol; 2019 Mar; 73(8):919-931. PubMed ID: 30819360
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use.
Lee SR; Choi EK; Kwon S; Jung JH; Han KD; Cha MJ; Oh S; Lip GYH
Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e005894. PubMed ID: 32160790
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for stroke and choice of oral anticoagulant in atrial fibrillation.
Kjerpeseth LJ; Ellekjær H; Selmer R; Ariansen I; Furu K; Skovlund E
Eur J Clin Pharmacol; 2018 Dec; 74(12):1653-1662. PubMed ID: 30116828
[TBL] [Abstract][Full Text] [Related]
30. Factors That Affect Time to Switch From Warfarin to a Direct Oral Anticoagulant After Change in the Reimbursement Criteria in Patients With Atrial Fibrillation.
Park S; Je NK
J Cardiovasc Pharmacol Ther; 2020 Jan; 25(1):57-64. PubMed ID: 31405298
[TBL] [Abstract][Full Text] [Related]
31. Self-reported adherence to direct oral anticoagulants versus warfarin therapy in a specialized thrombosis service-a cross-sectional study of patients in a Canadian Health Region.
Bonsu KO; Young SW; Lee T; Nguyen HV; Chitsike RS
Eur J Clin Pharmacol; 2023 Jan; 79(1):117-125. PubMed ID: 36399203
[TBL] [Abstract][Full Text] [Related]
32. A Comparison of Oral Anticoagulant Use for Atrial Fibrillation in the Pre- and Post-DOAC Eras.
Brown JD; Shewale AR; Dherange P; Talbert JC
Drugs Aging; 2016 Jun; 33(6):427-36. PubMed ID: 27154397
[TBL] [Abstract][Full Text] [Related]
33. Veterans Affairs Medical Center Racial and Ethnic Composition and Initiation of Anticoagulation for Atrial Fibrillation.
Essien UR; Kim N; Hausmann LRM; Washington DL; Mor MK; Litam TMA; Boyer TL; Gellad WF; Fine MJ
JAMA Netw Open; 2024 Jun; 7(6):e2418114. PubMed ID: 38913375
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
[TBL] [Abstract][Full Text] [Related]
35. A mixed methodology, non-interventional study to evaluate the use of direct oral anticoagulants in UK clinical practice for patients with a first stroke associated with non-valvular atrial fibrillation: study protocol.
Bhat Y; Dixit A; Mistri A; Patel B; Quoraishi SH; Uprichard J
BMC Neurol; 2019 Nov; 19(1):306. PubMed ID: 31783738
[TBL] [Abstract][Full Text] [Related]
36. Three-Year Clinical Outcomes Associated With Warfarin vs. Direct Oral Anticoagulant Use Among Japanese Patients With Atrial Fibrillation - Findings From the SAKURA AF Registry.
Okumura Y; Yokoyama K; Matsumoto N; Tachibana E; Kuronuma K; Oiwa K; Matsumoto M; Kojima T; Hanada S; Nomoto K; Arima K; Takahashi F; Kotani T; Ikeya Y; Fukushima S; Itou S; Kondo K; Chiku M; Ohno Y; Onikura M; Hirayama A;
Circ J; 2018 Sep; 82(10):2500-2509. PubMed ID: 30078823
[TBL] [Abstract][Full Text] [Related]
37. Trends of anticoagulant use and outcomes of patients with non-valvular atrial fibrillation: Findings from the RAFFINE registry.
Miyazaki S; Miyauchi K; Hayashi H; Yamashiro K; Tanaka R; Nishizaki Y; Nojiri S; Suwa S; Sumiyoshi M; Nakazato Y; Urabe T; Hattori N; Minamino T; Daida H
J Cardiol; 2022 Jul; 80(1):41-48. PubMed ID: 35346556
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease.
Bhatia HS; Bailey J; Unlu O; Hoffman K; Kim RJ
Pacing Clin Electrophysiol; 2019 Nov; 42(11):1463-1470. PubMed ID: 31599969
[TBL] [Abstract][Full Text] [Related]
39. Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation.
Law SWY; Lau WCY; Wong ICK; Lip GYH; Mok MT; Siu CW; Chan EW
J Am Coll Cardiol; 2018 Jul; 72(3):271-282. PubMed ID: 30012320
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology of atrial fibrillation-related ischemic stroke and its association with DOAC uptake in Spain: first national population-based study 2005 to 2018.
Díaz-Guzmán J; Freixa-Pamias R; García-Alegría J; Pérez Cabeza AI; Roldán-Rabadán I; Antolin-Fontes B; Rebollo P; Llorac A; Genís-Gironés M; Escobar-Cervantes C
Rev Esp Cardiol (Engl Ed); 2022 Jun; 75(6):496-505. PubMed ID: 34518112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
